Skip to main content
OpenTrials
Completed

NCT Number: NCT00476606

A Prospective Cohort of Children With HIV Infection

To evaluate clinical and immunological outcome of children treated with HAART.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infections Blood-Borne Infections Communicable Diseases Genital Diseases Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

1 day–20 year

Sex eligibility

All sexes

Study type

Observational

Primary location

HIV-NAT, Bangkok, Thailand

Loading trial locations.

About this study

This is a long term cohort study that was started in 2002. Currently, there are 120 children enrolled in the study and are receiving HIV care according to standard practice set by the Thai Ministry of Public Health. HIV-infected parents also receive care at the same clinic.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children who are part of the ATC program at Chulalongkorn hospital and at HIV-NAT, The Thai Red Cross AIDS research center
  • Children who fulfil criteria to start HAART according to the ATC program
  • Children who are switched to second regimen or salvage therapy
  • Children who are on any antiretroviral regimens, including post trial children from other HIV-NAT study (both at HIV-NAT and Khon Kaen University sites)
  • Children with HIV infection who are not on antiretroviral therapy
  • Caretakers understand the purpose of data and plasma samples collection, and have signed the consent form

Exclusion criteria

  • Patients and caretakers may choose to stop HAART at anytime during the study. If they agree, we would continue to follow them in this study.

Treatment and study plan

Zidovudine, Stavudine, Didanosine, Lamivudine

Drug

Refer to the Thai guideline for HIV management 2007

Nevirapine, Efavirenz

Drug

Refer to the Thai guideline for HIV management 2007

LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir

Drug

Refer to the Thai guideline for HIV management 2007

Primary outcomes

  1. 1. To collect clinical and immunologic data of children treated with HAART 2. To collect clinical outcome data on children with HIV infection 3. To provide the best possible care to children with HIV infection

    Time frame: every 3 months

Sponsors and collaborators

Lead sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Other

Collaborators

  • Khon Kaen University

Registry information

Official study title

Treatment Outcome of Children With HIV Infection

Important dates

Study start
2003
Primary completion
2024
Study completion
2024
First posted
May 22, 2007
Registry last updated
Mar 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.